Drug Profile
Dexamfetamine - Arbor Pharmaceuticals
Alternative Names: AR 11; ZenzediLatest Information Update: 26 May 2022
Price :
$50
*
At a glance
- Originator Arbor Pharmaceuticals
- Class Amphetamines; Behavioural disorder therapies; Sleep disorder therapies
- Mechanism of Action Adrenergic receptor agonists; Central nervous system stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Attention-deficit hyperactivity disorder; Narcolepsy
Most Recent Events
- 30 Jun 2013 Launched for Attention-deficit hyperactivity disorder (in children) in USA (PO)
- 30 Jun 2013 Launched for Narcolepsy in USA (PO)